Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids

NCT01563913 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

FED

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Docosahexaenoic Acid (DHA)
DRUG: Placebo

Sponsor

VA Office of Research and Development

Collaborators

[object Object]